Four plan lengths, none priced
Both product cards state that monthly, three, six and twelve-month options are available, and then print a single figure introduced by the words as low as. That figure necessarily belongs to the longest commitment, and the page does not say so or price the other three.
This is the commonest shape of unhelpfulness on this roster and it is worth naming precisely. A floor attached to an unstated term is not a price; it is the cheapest thing the seller is willing to be quoted on. Seventy-eight of the one hundred and fifty-eight sellers here have a headline figure that is promotional, introductory, or conditioned on a commitment the number does not disclose.
The tirzepatide card and the semaglutide card carry different floors, so the two lanes are at least separated. The site footer repeats the semaglutide floor and adds a separate NAD+ floor.
No membership required, and a membership terms page
Every plan card on the plans page prints the words no membership required. Fifty-five of the one hundred and fifty-eight sellers here state that no membership fee applies, and stating it plainly is genuinely better than leaving it blank, which sixty-four of the one hundred and fifty-eight sellers here do.
The same site publishes a document headed Membership Terms and Conditions, whose opening sentence asks the reader to read it carefully before enrolling in any membership plan, and which governs fixed-duration and subscription-based memberships. The operating company is named in that document, in its doing-business-as form, with a street address.
Both statements are the seller's own and we record both. The likeliest reading is that the subscription is the membership and no separate fee sits on top of it, but the site never says that, and we are not going to say it for them.
The illustration that looks like a disclosure
The product page shows a mock message thread illustrating the refill experience, in which a message appears from a Dr. Walsh. No clinician of that name, or any name, is identified anywhere on the site as someone who prescribes here.
That is a distinction worth holding onto. A name in a screenshot is set dressing. One hundred and eight of the one hundred and fifty-eight sellers here name nobody who prescribes, and this is one of them; the illustration does not change that.
No compounding pharmacy is named either. The page states that the product comes from a 503A pharmacy and is compounded to the prescription, which describes a class rather than a company. One hundred and twenty-six of the one hundred and fifty-eight sellers here name no pharmacy.
The FDA letter
FDA wrote to this seller in September 2025, having reviewed the website the month before, and found its claims about compounded semaglutide and tirzepatide false or misleading under the misbranding provisions of the Act.
Twenty-one of the one hundred and fifty-eight sellers here carry a warning letter. It is disclosed and it moves nothing. What is worth recording is the search: keying the FDA record to this seller's domain returns nothing, and the letter appears only when the brand name is searched. A screen built on domains produces a clean roster and a false one.
LumiMeds's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $89/mofrom, per month; the plan card states monthly, 3, 6 and 12-month options are available without saying which term produces this figure | September 2026source |
| Tirzepatide (compounded) | $125/moas low as, per month; the product page states monthly, 3, 6 and 12-month options are available without saying which term produces this figure | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See LumiMeds's current price →Good fit if
- Readers who want the membership question answered on the card, beside the price, rather than buried or omitted.
- Buyers who want a published telephone number and staffed hours attached to a telehealth brand.
- People shopping the bottom of the market who understand that the figure quoted is a floor on a long commitment.
Look elsewhere if
- Anyone who needs to know what a month costs. Four plan lengths are offered and none is priced.
- Readers for whom an FDA warning letter about website claims is disqualifying.
- Buyers who want the compounding pharmacy or an actual prescribing clinician named.
- People who need a service-area list.
How this review was verified
- Re-read the tirzepatide plan page, the site root and the membership terms on 6 September 2026, taking every figure from joined text nodes rather than from raw markup.
- Compared the requested path to the effective path on every fetch. The plans address recorded in the research file redirects to the site root, so the semaglutide figure is cited to the address that actually served it.
- Ran a nonsense path against this host in the same run; it returned a not-found status.
- Recorded the no-membership-required wording and the existence of the membership terms document as two separate readings rather than resolving them into one claim.
- Screened the brand name and the operating entity against FDA's live warning-letter record with a positive and a negative control in the same pass, and confirmed that a domain-keyed search of the same record returns nothing for this seller.
- Re-fetched the letter and confirmed its title names this exact brand, number and date, against a minted nonsense letter path on fda.gov in the same run that returned a not-found status. Untitled letters are published separately and were not searched.